COVID-19 Daily Update 8-4-2022 – West Virginia Department of Health and Human Resources

The West Virginia Department of Health and Human Resources (DHHR) reports as of August 4, 2022, there are currently 3,036 active COVID-19 cases statewide. There have been four deaths reported since the last report, with a total of 7,173 deaths attributed to COVID-19.

DHHR has confirmed the deaths of a 93-year old female from Marion County, a 75-year old male from Harrison County, a 78-year old male from Mercer County, and a 98-year old female from Harrison County.

Each death of a West Virginian is a loss felt by all, said Bill J. Crouch, DHHR Cabinet Secretary. We extend our sincere condolences to these families and encourage all eligible individuals to get vaccinated and boosted.

CURRENT ACTIVE CASES PER COUNTY: Barbour (48), Berkeley (161), Boone (50), Braxton (17), Brooke (28), Cabell (144), Calhoun (8), Clay (6), Doddridge (8), Fayette (83), Gilmer (9), Grant (8), Greenbrier (69), Hampshire (33), Hancock (32), Hardy (47), Harrison (109), Jackson (41), Jefferson (77), Kanawha (267), Lewis (21), Lincoln (45), Logan (81), Marion (91), Marshall (62), Mason (53), McDowell (50), Mercer (137), Mineral (37), Mingo (56), Monongalia (123), Monroe (45), Morgan (21), Nicholas (38), Ohio (73), Pendleton (7), Pleasants (7), Pocahontas (13), Preston (23), Putnam (113), Raleigh (180), Randolph (17), Ritchie (13), Roane (37), Summers (22), Taylor (25), Tucker (12), Tyler (13), Upshur (35), Wayne (55), Webster (19), Wetzel (13), Wirt (9), Wood (198), Wyoming (47). To find the cumulative cases per county, please visit coronavirus.wv.gov and look on the Cumulative Summary tab which is sortable by county.

West Virginians ages 6 months and older are recommended to get vaccinated against the virus that causes COVID-19. Those 5 years and older should receive a booster shot when due. Second booster shots for those age 50 and over who are 4 months or greater from their first booster are recommended, as well as for younger individuals over 12 years old with serious and chronic health conditions that lead to being considered moderately to severely immunocompromised.

Visit the WV COVID-19 Vaccination Due Date Calculator, a free, online tool that helps individuals figure out when they may be due for a COVID-19 shot, making it easier to stay up-to-date on COVID-19 vaccination. To learn more about COVID-19 vaccines, or to find a vaccine site near you, visit vaccinate.wv.gov or call 1-833-734-0965.

To locate COVID-19 testing near you, please visit https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

View original post here:

COVID-19 Daily Update 8-4-2022 - West Virginia Department of Health and Human Resources

COVID-19 update as of Aug. 4: Cook County stays in high community risk level, Evanston in the medium risk level – Evanston RoundTable

The total number of new cases of COVID-19 in Evanston was 163 for the week ending Aug. 3, compared to 185 for the week ending July 28, a decrease of 12%. The seven-day average of new cases in the state also decreased by 12%; hospitalizations declined by 4%.

Cook County, including Chicago, remained in the high community risk level. City officials say Evanston is in the medium risk level.

The number of new cases being reported is significantly lower than the actual number of new cases being contracted because many new cases are not being reported. [1] Some researchers estimate that the actual number of new cases is between six and ten times higher than the number being reported.

Illinois: On Aug. 4, the number of new cases in the state was 4,149.

The seven-day average of new cases in Illinois on Aug. 4 was 4,345, down from 4,962 on July 28, a12.4% decrease. The chart below shows the trend.

Evanston: Evanston reported there were 28 new COVID-19 cases of Evanston residents on Aug. 3. (Evanston is reporting COVID-19 data with a one-day delay.)

There was a total of 163 new COVID-19 cases of Evanston residents in the week ending Aug. 3, compared to 185 new cases in the week ending July 28, a decrease of 12%.

The chart below shows the trend.

No Evanstonians died due to COVID-19 during the week ending July 28. The number of deaths due to COVID-19 remains at 155.

Northwestern University. The latest data reported on NUs website shows that between July 22 and July 28, there were 65 new COVID-19 cases of faculty, staff or students. Cases of Evanston residents are included in Evanstons data for the relevant period, Ike Ogbo, Director of Evanstons Department of Health and Human Services, told the RoundTable. NU will update its data tomorrow.

The weekly number of new cases per 100,000 people in Illinois is 239 in the seven days ending Aug. 4.

As of Aug. 3, the weekly number of new cases per 100,000 people in Evanston was 220. As of Aug. 4, the number was 211 for Chicago, and 226 for Suburban Cook County. An accompanying chart shows the trend.

There were 1,416 hospitalizations in Illinois due to COVID-19 on Aug. 3, compared to 1,476 one week ago.

The chart below, prepared by the City of Evanston, shows the trends in hospitalizations due to COVID-19 at the closest two hospitals serving Evanston residents.

The CDC and IDPH look at the combination of three metrics to determine whether a community level of risk for COVID-19 is low, medium, or high. They are: 1) the total number of new COVID-19 cases per 100,000 people in the last 7 days; 2) the new COVID-19 hospital admissions per 100,000 in the last 7 days; and 3) the percent of staffed inpatient hospital beds occupied by COVID-19 patients. [2]

The City of Evanston reported this evening, Aug. 4, that Evanston is in the mediumrisk category. IDPH reported today that Cook County, including Chicago, is in the high risk category. Lake, DuPage, Will, Kane, and McHenry Counties are also in the high risk category.

While Evanston has more than 200 new cases per 100,000 people, the city reported this evening that Evanston has a 7-day total of 5.12 new hospital admissions per 100,000 people, and that it has 2.61% staffed inpatient hospital beds that are occupied by COVID patients (using a 7-day average).

The city has not said which hospitals or how many hospitals it is considering in making its analysis of community risk.

The CDC and IDPH recommend that people in a community with a high transmission rate should take the following precautions:

FOOTNOTES

1/The City of Evanston says that the State, the County and the City do not have a mechanism to report, verify or track at home test results. Because a positive at home test is regarded as highly accurate, most people who test positive in an at home test do not get a second test outside the home that is reported to government officials. The number of new COVID-19 cases reported by IDPH and the City thus significantly understates the actual number of new cases that are contracted. Some studies estimate the cases are underestimated by 600% or more.

2/ CDC recommends the use of three indicators to measure COVID-19 Community Levels: 1) new COVID-19 cases per 100,000 population in the last 7 days; 2) new COVID-19 hospital admissions per 100,000 population in the last 7 days; and 3) the percent of staffed inpatient beds occupied by patients with confirmed COVID-19 (7-day average).

The chart below illustrates how these indicators are combined to determine whether COVID-19 Community Levels are low, medium, or high. The CDC provides many recommendations depending on whether the COVID-19 Community Level is low, medium, or high.

Read more here:

COVID-19 update as of Aug. 4: Cook County stays in high community risk level, Evanston in the medium risk level - Evanston RoundTable

Pedagogies, Communities, and Practices of Care after COVID-19 – Knox College

The Mellon Foundation awarded $150,000 to Knox College for a research project entitled Pedagogies, Communities, and Practices of Care after COVID-19. Cate Denial, Bright Distinguished Professor of American History, chair of History, and director of the Bright Institute, is the principal investigator.

Over the past two years, administrators, faculty, and staff have held higher education together with willpower and determination in the face of a global pandemic. The result, for many, has been burnout and exhaustion. This project responds to that crisis with a plan to identify, cultivate, and support national leadership in applying practices of compassion and care to working conditions in higher education. Denial will coordinate 36 individuals from community colleges, four-year institutions, regional states, and flagship research institutions, including online educators. These individuals, representing diverse social identities, will explore the meaning of, and opportunities within, a practice of care in the academy.

Im so grateful for the encouragement and support of the Mellon Foundation in funding this project, said Denial. Care and compassion offer a strong foundation from which to build, change, and rethink community as the pandemic continues. Faculty and staff working conditions are student learning conditions, making it particularly important to think critically about the ways in which we labor, and new approaches to work that will increase accessibility, employ trauma-informed practices, and evolve our pedagogies to affirm that care is at the center of what we do.

Read more:

Pedagogies, Communities, and Practices of Care after COVID-19 - Knox College

Monkeypox can’t use the same at-home testing playbook as COVID-19 – The Verge

After two years of COVID-19, the conversation around monkeypox testing gives off an unnerving sense of deja-vu. The similarities are right there: painful swabs, the struggle to even find a test, bottlenecks, and a long wait for results. But the diseases are different enough that experience with COVID-19 didnt give researchers much of a leg up in their efforts to improve the monkeypox testing process.

In the early days of the COVID-19 pandemic, experts bemoaned the lack of investment in rapid, at-home testing for various diseases in the United States. The thought was that if the infrastructure had been in place before the coronavirus emerged, it would have been easier to scale up testing and maybe help control the pandemic. Eventually, that scale-up happened anyway. Money and resources flooded into testing projects, and soon, at-home COVID-19 tests became ubiquitous. That experience was supposed to set the stage for a future with easy access to home tests for any number of diseases once they popped onto the scene.

Against that backdrop, it would seem that monkeypox might offer a perfect test case. Its an unfamiliar disease spreading rapidly, and theres high demand for tests. But monkeypox isnt the best benchmark for whether that future is going to materialize, says Ben Pinsky, the medical co-director for point of care testing at Stanford Health Care. Its a different enough infection, he says.

Monkeypox isnt a respiratory disease like COVID-19, where the nose and mouth are the clear targets both for the virus and for testing. Monkeypoxs telltale signs are painful, blister-like sores, and it can come with other symptoms like fever and muscle aches. Right now, monkeypox tests involve swabbing the sores that appear over the course of an infection. There arent at-home tests for other lesions like herpes, for example, Pinsky says. There is still a lot of work to do to figure out if people are able to successfully swab their own lesions, which could be painful or difficult, he says.

The reliance on lesions means that patients can only be tested once the telltale signs of the disease appear which is a sign they probably should be isolated from others anyway. Someone who was exposed to monkeypox and has a fever but no lesions wouldnt be able to take a test. People can test for COVID-19, on the other hand, without waiting for any specific symptoms to appear. Im a strong advocate for home testing of diseases, but you have to have the right sample at the right time, and we arent there yet, says Paul Yager, a professor in the department of bioengineering at the University of Washington, in an email to The Verge.

It might be possible to test for monkeypox through saliva or semen, according to one small study of 12 patients done in June. And some companies are working on tests that dont involve lesions at all. A California-based company, Flow Health, developed a saliva-based molecular test for monkeypox, which asks people to spit in a tube and then send in the sample for PCR testing.

The test is not authorized or approved by the Food and Drug Administration. Its offered through a program that lets certified labs develop and run their own in-house tests without going through the normal regulatory process. Right now, the FDA still says monkeypox tests should be run on lesions. The company is sharing its saliva test data with the FDA as the agency checks to see if it should update its guidance, Flow Health CEO Alex Meshkin told The Verge.

Theres still a lot of work to do in order to figure out how and when the monkeypox virus shows up in different parts of the body over the course of the disease, which will influence how effective and accurate tests that dont use lesions might be. If the monkeypox virus shows up in saliva before lesions develop, for example, then a saliva-based test could help flag the disease early on. But if it doesnt, that type of test might not be as useful. Meshkin says Flow Health has tested someone who closely interacted with monkeypox patients but didnt yet have lesions and that the tests of that person came up positive. Itll take testing more patients, though, to know for sure when and how the virus shows up.

Along with the science being different, the regulatory and political landscape around monkeypox also breaks from COVID-19. At the moment, monkeypox hasnt been declared a federal public health emergency in the United States. That changes the way various groups might go about developing tests. Right now, COVID-19 at-home tests are primarily available under emergency use authorizations an accelerated process that lets tests come to market more quickly during an emergency. Meshkin says Flow Health is prepared to file for an emergency use authorization if a public health emergency is declared, which reports say could come this week.

Without the emergency authorization, companies that do home testing arent able to take some of the same steps that they did during the early stages of the COVID-19 pandemic. They also cant take the approach of Flow Health, which doesnt need FDA signoff to run saliva tests at its lab. An at-home test, by definition, doesnt use a lab to start diagnosing patients. Those factors may contribute to why many rapid testing platforms that sprang up in response to COVID-19 didnt pivot straight to monkeypox. Cue Health, which has a rapid molecular COVID-19 test, is working on a variety of diagnostics tests but didnt specify which they were, spokesperson Shannon Olivas said in an email to The Verge. Detect, which also has a rapid molecular COVID-19 test, said its in the concept phase for a monkeypox test, chief technology officer Eric Kauderer-Abrams said in an email to The Verge.

Those are all reasons why monkeypox testing takes more work than building directly on the COVID-19 experience. But they arent excuses. The health system could still have been far better prepared for this particular outbreak. The disease has been common in Africa for years, but global public health has largely failed to devote resources to understanding and preventing it. A Nigerian doctor who tried to raise alarms about the disease in 2017 wasnt taken seriously by officials and the international medical community. If thered been more attention to the disease over the past few years, infectious disease experts might have a better understanding of how the virus affects the body giving them the type of information theyd need to develop easier home tests more quickly.

Even if we set aside home testing and the logistical differences between the two diseases, youd think that, after two years of a brutal pandemic, the US would have learned how urgent testing can be to get a handle on an infectious disease outbreak. Theres still more demand for testing than there are tests available, and some people who suspect they have the disease are being dismissed by doctors while they struggle to manage painful symptoms. Unlike the start of the COVID-19 pandemic, monkeypox is a known disease with existing tests, treatments, and vaccines, but the sluggish response to US outbreaks shows just how few lessons the public health system has learned even after a two-year crash course in how disease can disrupt the world.

Link:

Monkeypox can't use the same at-home testing playbook as COVID-19 - The Verge

Covid-19, Gender And Immune Response: What’s The Relationship? (Part Two) – Forbes

This is the second installment in a two part series which analyzes biological sex differences in immune responses to SARS-CoV-2 infection. Part one focuses primarily on Covid-19 related viral entry, innate and adaptive immune responses to Covid-19 and their correlation to epidemiological evidence. This article will highlight the role of sex hormones in SARS-CoV-2 immune responses, examine sex differences in response to vaccines, and consider their possible therapeutic implications.

Paper cut out illustration of a man and a woman facing each other

Covid-19 disease severity and mortality differ between men and women, but the reasons for such differences are not well understood. Part one of this series delves into sex differences in response to SARS-CoV-2 infection and notes how stronger immune responses seen in females likely contribute to the better outcomes observed. This second and final installment will analyze two more elucidating factors: the role of sex hormones on SARS-CoV-2 immune responses and sex differences in immune responses to vaccines. These components, in particular, pose potential therapeutic directions for treating and understanding Covid-19.

Sex Hormones and SARS-CoV-2 Immune Responses

FIGURE 1: Men possess higher levels of androgens such as testosterone and dihydrotestosterone. Women, in contrast, have elevated levels of estrogen and progesterone. The first section of this article will concentrate on the role of androgens, estrogen and progesterone on Covid-19 disease progression and outcomes.

Androgens

In their review The Immune Response to Covid-19: Does sex matter?, Ho et al. analyze the complex relationship between sex hormones and SARS-CoV-2 immune response. They first consider androgenssuch as testosterone and dihydrotestosteronewhich males possess higher levels of than females.

Ho et al. find that androgen receptor expression may impact two essential enzymes to SARS-CoV-2 viral entry: furin and transmembrane serine protease 2 (TMPRSS2). Furin is a calcium-dependent enzyme which cleaves the spike protein into the configuration needed for priming and activation. Transmembrane serine protease 2 (TMPRSS2) primes the SARS-CoV-2 protein for entry into host cells. The theory is, since increased androgen receptor expression can upregulate furin and TMPRSS2, the higher androgen receptor expression seen in men increases their susceptibility to severe forms of Covid-19.

Although the clinical association observed between androgenic alopecia and severe Covid-19 would suggest this mechanism to be true, studies on androgen deprivation therapy (ADT) in prostate cancer patients with Covid-19 do not necessarily support this claim. Androgen deprivation therapy reduces the number of androgen receptors available for activation through medicine or surgery. The therapy was expected to decrease androgen receptor expression in prostate cancer patients with Covid-19, thereby restricting androgen regulation of TMPRSS2 and reducing the risk of SARS-CoV-2 infection. In contrast to this notion, the treatment did not improve infection risk, ICU admission, hospitalization or mortality in comparison to controls.

Randomized clinical trial results with antiandrogens, medicines which block androgen receptors and inhibit androgen synthesis, further complicate these associations. One randomized controlled trial revealed that Covid-19 patients given nitazoxanide/azithromycin therapy with antiandrogen dutasteride experienced decreased viral shedding, inflammatory markers and time-to-remission compared with placebo; another found that antiandrogen proxoludamine reduced the 30-day hospitalization rate and risk ratio amongst men with Covid-19. On the other hand, a third trial with enzalutamide increased Covid-19 related hospitalization stay.

Male sex steroids seem to perform varying roles with respect to Covid-19. The culminating conclusion from these studies suggests that both low and high androgen levels can correlate with poor Covid-19 prognoses. As Ho et al. state in their review, further investigation in this arena is needed.

Estrogens

Female sex hormone estrogen appears to mediate several beneficial immune responses. A study of hospitalized Covid patients correlated higher estradiol levels to decreased disease severity. And as mentioned in part one, estrogen promotes strong immune responses in women and likely contributes to the observed discrepancy in innate and adaptive immune responses between sexes.

Inflammation in female innate immune responses reduces when estrogen activates anti-inflammatory cytokines, inhibits the nuclear factor kappa B (NF-B) pathway, and decreases the release of inflammatory cytokines. Women also have better priming of adaptive immune responses to viruses. This is thought to be influenced by estrogen; estrogen can help regulate immune cells called plasmacytoid dendritic cells (pDCs) which, in turn, promote the production of interferon alpha, an important antiviral cytokine in innate immunity. These mechanisms may translate to the better disease outcomes witnessed in women than men with Covid-19.

Estrogen has also been found to regulate several proteins which are involved in SARS-CoV-2 viral entry: furin, TMPRSS2, angiotensin converting enzyme 2 (ACE2) and a disintegrin and metalloprotease 17 (ADAM17). It, too, suppresses immune enzyme dipeptidyl peptidase 4 (DPP4), thereby blocking another potential means of SARS-CoV-2 viral entry.

Researchers are exploring possible therapeutic applications for estrogen in Covid-19 interventions. Two examples include a study on the effect of selective estrogen receptor modulators on Covid-19, and a randomized control trial analyzing the efficacy of an estradiol/progesterone therapy in reducing disease severity in hospitalized Covid patients.

Progesterone

Ho et al. complete their study of sex hormones in Covid-19 with progesterone. Progesterone levels tend to be higher in women than men and are associated with general anti-inflammatory effects. These anti-inflammatory effects include but are not limited to the ability to increase T regulatory cells, enhance antiviral immune pathways and disrupt endocytic pathways used by viruses to enter host cells. It is hypothesized, therefore, that progesterone may decrease the risk of hyperinflammation and SARS-CoV-2 related cytokine storm.

There is therapeutic potential in administering progesterone to treat Covid-19. A study of hypoxemic men hospitalized with Covid-19 observed that short term subcutaneous progesterone decreased hospitalization stay and supplemental oxygen needed. Additional research is needed to understand the specific mechanisms at work and its promising impacts on Covid-19 treatments.

Sex Differences in Vaccine Immune Responses

Vaccines are crucial to Covid-19 control and have been invaluable in reducing lives lost to severe forms of the disease. As a result, Ho et al. emphasize the importance of understanding sex differences in response to Covid-19 vaccines. They state, sex differences should be taken into account as a biological variable for adjusting sex-personalized vaccine dosage and considering vaccine efficiency.

These considerations seem most pertinent to women. Two studies, one systematic review and one meta analysis, found that vaccination prevented Covid-19 disease less effectively in women than in men. Similarly, a 2021 CDC report observed that women received 61% of administered Covid-19 vaccines at the time yet accounted for 79% of adverse events. The discrepancies in vaccine response could be due to several factorsage, hormonal differences (as explored in this article) and sex differences intrinsic to SARS-CoV-2 immune response (see part one of this series)but more studies are needed to clarify these possible correlations.

Conclusions

Contemporary research reveals that sex hormones and biological sex do influence immune responses and vaccines, although specific mechanisms have yet to be fully understood. Ho et al. call for biological sex to be considered in basic, translational and clinical Covid-19 research. More extensive research on biological sex and Covid-19 could open potential therapeutic avenues and improve the specificity of those strategiesbe it through the use of sex hormone therapies or through the adjustment of vaccine dosage based on gender.

Read the original post:

Covid-19, Gender And Immune Response: What's The Relationship? (Part Two) - Forbes

God, No, Not Another Case. COVID-Related Stillbirths Didn’t Have to Happen. – ProPublica

This story contains descriptions of stillbirths.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every week.

Late one afternoon last October, Dr. Shelley Odronic sat in her office and, just as she had thousands of times before, slid a rectangular glass slide onto her microscope.

A pathologist who works in rural Ohio, Odronic leaned forward to examine tissue from the placenta of a woman who had recently given birth. She increased the magnification on the microscope. Never had she seen so many tiny, congealed reservoirs of blood or such severe inflammation of the tissue, a sign the placenta had been fighting an infection.

Right away, I knew it wasnt compatible with life, Odronic said.

She asked her secretary to print out the patients chart. In dark letters were the words fetal demise. A stillbirth, the death of a fetus at 20 weeks or more of pregnancy. But that didnt solve the mystery. Odronic had examined many placentas from pregnancies that ended in stillbirth. None looked like this withered and scarred.

Odronic kept reading. No chronic medical conditions. Good prenatal care. Then, buried in the middle of the report, she spotted something. Seven days before the stillbirth, the mother had tested positive for COVID-19. Odronic wondered if the virus could explain the damage to the placenta. In the world of placenta pathology, a new affliction is unusual, especially one so dramatic in presentation and so devastating in effect.

Her mind traveled to Dr. Amy Heerema-McKenney, a pathologist at Cleveland Clinic and an expert on the placenta, who had trained Odronic during residency. Odronic went to sleep that night with a pit in her stomach and a plan to call her former teacher in the morning.

Heerema-McKenney was in her office when the phone rang. As she listened, she knew that what Odronic was describing was what she and her colleagues had observed repeatedly over the past several months: a patient positive for the coronavirus, a placenta destroyed by COVID-19, a baby stillborn.

Their next discovery was equally stunning. None of the stillbirths they studied involved a pregnant person who had been fully vaccinated. The doctors checked with colleagues across the country and around the world. The fatal pattern held.

Unvaccinated women who contracted COVID-19 during pregnancy were at a higher risk of stillbirths. They also were more likely to be admitted to the intensive care unit, give birth prematurely or die. Yet their greatest protection the COVID-19 vaccine sat largely untouched, buried under doubt, polluted by disinformation.

How Misinformation About COVID Vaccines and Pregnancy Took Root Early On and Why It Wont Go Away

Pharmaceutical companies and government officials failed to ensure that pregnant people were included in the early development of the COVID-19 vaccine, a calamitous decision made amid the urgency of a rapidly spreading pandemic. That decision left pregnant people with little research to rely on when making a critical decision on how best to keep the babies growing inside of them safe.

At the same time that research was excluding pregnant people from vaccine trials, a full-scale assault on vaccination was unfolding online. Taking advantage of the lack of data, conspiracy theorists, anti-vaxxers and even some medical professionals spread false claims about the vaccines safety in pregnancy, leading many pregnant people to delay or refuse the vaccine. Even now, with numerous studies unequivocally announcing the safety of the vaccine for pregnant people, some doctors have failed to communicate the dangers of COVID-19 to pregnant people or the vaccines role in mitigating it.

The Centers for Disease Control and Prevention contributed to the confusion with vague early messaging about whether pregnant people should get vaccinated. While Americans lined up at pharmacies and stalked vaccine websites in hopes of securing a shot last year, pregnant people had some of the lowest vaccination rates among adults, with only 35% fully vaccinated by last November. Meanwhile, many Americans were already moving on to their boosters after federal officials that month expanded eligibility for the additional shots to anyone 18 or older. And much of the country was beginning to return to pre-pandemic life. The Sunday after Thanksgiving, for instance, set the record for the busiest day of air travel since March 2020.

November also marked a key moment in the understanding of COVID-19s impact on stillbirths. A CDC study looking at 1.2 million births in the first 18 months of the pandemic found that more than 8,000 pregnancies ended in stillbirths, including more than 270 of them in patients with a documented COVID-19 diagnosis at the time of delivery.

Although stillbirths were rare overall, babies were dying. The risk of a stillbirth nearly doubled for those who had COVID-19 during pregnancy compared with those who didnt. And during the spread of the delta variant, that risk was four times higher.

Indeed, doctors discovered that some stillbirths resulted from COVID-19 directly infiltrating the placenta, a condition they named SARS-CoV-2 placentitis. Cases were found even in people whose COVID-19 symptoms were mild or nonexistent. In some cases, however, placentas were discarded with medical waste without being tested for COVID-19, and parents never learned what led to their babys stillbirth.

COVID-19 also led to stillbirths among pregnant people who became exceedingly ill after contracting the virus. It damaged their lungs and clotted their blood, putting their babies in such severe distress that they were born before they could take their first breath.

These are pregnancies that should not have ended, Heerema-McKenney said.

She and others had tried to alert the CDC as well as maternal and state health organizations to their findings, but she said they either didnt get a response or were told they needed to collect more data and publish studies. Pathologists are experts in disease diagnosis, dealing with death and illness from the safe distance of their labs. Convincing obstetricians who met with patients daily or doctors who were making policy recommendations was a challenge.

I tried to sound the alarm. We tried so hard to get people to listen, Heerema-McKenney said. It was a really frustrating place to be as pathologists doing these autopsies, looking at these placentas and saying, God, no, not another case.

Around the same time Heerema-McKenney was examining the damaged placentas, Ginger Munro was on life support in a hospital 250 miles away in another part of Ohio.

She and her husband, Kendal, had been trying to have a child for five years. They hadnt expected that shed get pregnant in the middle of a pandemic. But when her pregnancy test came back positive in the spring of 2021, she rushed to post a picture of it in an online pregnancy group. Is it just me or can you see the 2 lines?? she asked.

The pandemic had already brought much change to their lives. Ginger, who lives in the small town of Washington Court House in southwest Ohio, quit her job as assistant nutrition director with the countys Commission on Aging. She stationed hand sanitizer throughout her house and in her car, and she only went grocery shopping early in the morning. If she noticed someone in an aisle, she skipped it.

I knew the virus was real, she said, but I was terrified to take the vaccine.

Ginger worried that the vaccines development had been rushed, and she hadnt seen any data showing it was safe for pregnant people. At this point, the CDC had not explicitly recommended the vaccine during pregnancy. Ginger already worried she was tempting fate by getting pregnant at 40; she said she didnt want to risk endangering her baby by taking the vaccine.

Besides, if it was really important, her doctor would have mentioned it, and, she said, she would have followed his advice. But, she said, he never did. Her family hadnt gotten vaccinated either. In a mostly rural county where less than half of the residents were vaccinated, they were hardly alone.

Her doctor declined to comment through a spokesperson at the hospital system where he works; the spokesperson said the hospital couldnt disseminate information about the vaccine to pregnant patients before it was recommended.

Gingers pregnancy progressed without complications. She and Kendal shared the news of a new baby with Gingers two daughters from a previous marriage. At their kitchen table, near a sign that read eat cake for breakfast, Sophia, then 14, covered her mouth with both hands while Hailee, then 18, simply beamed.

At a backyard gender reveal three months later, Gingers growing belly resembled a basketball against her tiny frame. She leaned in to kiss her husband, her long, dark hair falling onto her shoulders. Red confetti rained down on the deck.

Kendal, an aircraft maintenance and avionics manager at an airport two counties away, worked through the pandemic. In the summer, when they realized his cough was actually COVID-19, it was too late. Ginger was sick.

What the Placenta Does

The placentas job is as critical as it is clear: keep the baby alive.

For the most part, it does that well. The placenta is the first organ to develop after conception, and it connects to the fetus through the umbilical cord, which delivers oxygen. The placenta provides nourishment, expels waste and does much of the work of the fetuss lungs, kidneys and liver as they develop. The dark-red organ typically is solid, with a sponge-like texture and blood vessels that spread out like the branches of a tree.

The placenta also acts as a shield against most viruses, but when its attacked by COVID-19, the branches can collapse, killing the cells, cutting off oxygen to the fetus, leaving holes to be filled by pools of blood. In response to the infected and dying cells, inflammation and scarring spread throughout the placenta.

Unable to survive the damage to the placenta, many babies were stillborn.

Having trouble reaching her doctor, she went to two different emergency rooms. One, she said, declined to treat her with monoclonal antibodies, which research had shown can be an effective treatment for pregnant people with COVID-19. The other, which described her in medical records as an exceedingly pleasant individual admitted with symptomatic COVID-19 pneumonia, transferred her about an hour away to the University of Cincinnati Medical Center. There, records show, she was admitted with acute respiratory distress syndrome due to COVID-19.

The University of Cincinnati doctor asked Ginger and Kendal who was on FaceTime because of the hospitals COVID-19 protocols about fetal priority. Ginger made her wishes clear: Save the baby, their baby, the baby they had tried so hard to have. Kendal, who was worried about both his wife and their unborn child, said he went along with Ginger in that moment.

You were so scared, Kendal wrote in a notebook that night. We told each other over and over how much we loved each other.

They hung up so the doctors could insert a breathing tube. Before they could begin, Kendal called back three more times just to hear her voice.

Doctors put Ginger on ECMO, a form of life support reserved for the sickest patients. Kendal, Hailee, Sophia and Gingers mother and sister were later allowed in the hospital two at a time, and they prayed at her bedside nearly every night. Ginger was sedated, her face swollen and obscured by tubing, her cheeks flattened by the crush of the ventilator straps, her wrists tied down so she wouldnt accidentally pull out her breathing tube.

Her family took solace in knowing the babys heartbeat was steady and her ultrasounds were normal. The doctors gave Ginger medication to help the babys lungs mature in case she was born early. After more than 30 days on ECMO, doctors took Ginger off the machine only to put her back on the next morning. She was the first patient in the hospitals history to be placed on ECMO twice.

The plan, records show, was to deliver at 28 weeks. But the day after Ginger was put back on life support, Kendal got the call telling him the baby was on her way. As doctors prepared for the delivery in Gingers intensive care room, the family camped out in the waiting room, jittery from excitement and vending machine snacks. They talked about baby names and future family outings. They pulled the waiting room chairs together to form makeshift beds and covered themselves with blankets they brought from home.

They dont know if they actually fell asleep before a nurse burst through the doors screaming at them to follow. Shes coming! Shes coming! They didnt make it far before they were blocked by doctors and nurses, some huddled over an incubator in the middle of the hall and the rest crowded around Ginger.

Hailee tried to peer over the sea of blue scrubs to catch the first glimpse of her little sister. She smiled beneath her black mask. Shell be OK, she said to herself.

But after a few minutes of trying to revive the baby, a doctor told Kendal it was time. Kendal nodded, asked for a chair and collapsed as he tried to process his daughters death.

Then another wave of grief washed over him. Someone would have to tell Ginger.

Content Warning

Warning: The following image shows a stillborn baby. The Munro family had photos taken of their daughter to preserve their memory of her.

Gingers medical records describe a baby born at 27 weeks without signs of life after an uncomplicated delivery. Her placenta had separated from the wall of the uterus, the risk of which studies have shown increases with COVID-19.

When Ginger woke up, she looked down at her sunken belly and realized she had given birth. She assumed her daughter was in the newborn intensive care unit. Ginger was barely able to speak around the tube in her trachea, but after a few days in which no one brought the baby to her, she couldnt wait any longer. Ginger turned to her mother and sister and mouthed the words, Wheres the baby?

The room fell silent. They called Kendal, who rushed to the hospital. He told her what had happened. He described their daughters dark hair and her long fingers and toes, just like her mothers.

Ginger, who had always loved the sweet smell of a newborns breath, whispered to her husband.

Did you smell her breath?

She wasnt breathing, he said.

In the hurried quest for a safe and effective COVID-19 vaccine, pharmaceutical companies and government officials did not include pregnant people in their initial plans. Its a failure that continues to reverberate.

They absolutely should have been included in COVID vaccine trials from the beginning, said Kathryn Schubert, president and CEO of the Society for Womens Health Research, a Washington, D.C.-based nonprofit that advocates for the inclusion of women in research and clinical trials.

Researchers and advocates have spent more than four decades trying to dismantle the belief that its unsafe or unethical for pregnant women to participate in clinical trials. A couple years ago, it seemed like they had finally prevailed.

Shortly before leaving office, President Barack Obama signed into law the 21st Century Cures Act, which established the Task Force on Research Specific to Pregnant Women and Lactating Women. The group found longstanding obstacles, including liability concerns, to including pregnant and lactating people in clinical research. It concluded that recommending halting medication or forgoing treatment while pregnant may actually endanger the health of the mother and her fetus more than the treatment itself.

The need for everything from asthma to depression medication doesnt stop when a person gets pregnant, and when a catastrophic event such as a pandemic hits, experts said, pregnancy should not preclude someone from receiving life-saving treatment.

Around the same time, researchers discovered that the Zika virus, which was mainly transmitted through mosquitoes, could pass from a pregnant person to their fetus and cause severe birth deformities. A second group of experts joined together to develop separate guidance on including pregnant people in the research, development and deployment of pandemic vaccines.

Both groups pushed to remove pregnant women from a list of vulnerable populations that required additional review before being allowed to participate in research. Instead of proving that pregnant women should be included, manufacturers would need to provide compelling evidence for why they shouldnt.

In 2018, the federal task force issued recommendations calling for including pregnant and breastfeeding people in biomedical research, and the Department of Health and Human Services adopted some of the guidance. But a gap remained between what the task force and others insisted was needed and what was actually happening.

We were frustrated because COVID-19 provided an opportunity to implement the recommendations of the task force, said Dr. Diana Bianchi, the director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the chair of the task force.

In February 2021, Bianchi and her colleagues published an article lamenting the exclusion of those who were pregnant or breastfeeding from the initial COVID-19 vaccine clinical trials. Pregnant and lactating persons should not be protected from participating in research, but rather should be protected through research, they wrote.

Ruth Faden, the founder of the Johns Hopkins Berman Institute of Bioethics, helped lead the group that issued the guidance after Zika. She and others urged manufacturers to include pregnant people in the development of the COVID-19 vaccine as part of Operation Warp Speed, the federal program that provided billions of taxpayer dollars to pharmaceutical companies to speed up vaccine production.

There is a playbook in place so that when the U.S. launches Operation Warp Speed, it should be pretty obvious what should be done, she said. Its not like no one knows how to do this, either ethically or technically.

Nevertheless, it doesnt happen, Faden added. Once again, pregnant people are left behind.

A spokesperson for Pfizer said the company followed guidance from the Food and Drug Administration. Although pregnant people were not included in the initial vaccine clinical trials, Pfizer tested its vaccine on pregnant rats and did not identify any safety concerns. The company subsequently launched a clinical trial with pregnant women but halted it because at that point the vaccine had already been recommended for pregnant people.

Similarly, Moderna also studied its vaccine on pregnant animals, but the company said it made the decision to prioritize the study of the safety and efficacy of the vaccine in adults who werent pregnant. It called that approach consistent with the precedent to study new vaccines in pregnant women only after demonstration of favorable benefit and risk in healthy adults.

In response to questions from ProPublica, Johnson & Johnson referred a reporter to its website, which didnt address the relevant issues.

Some government officials, including several from the Food and Drug Administration, said they support having pregnant women take part in clinical studies of vaccines for emerging infectious disease, including COVID-19. A spokesperson for the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health, said the agency did not dictate the protocol development for the trials and said that responsibility lies with the companies.

The failure to include pregnant people early on in COVID-19 vaccine trials was, at least in part, a casualty of the tremendous urgency to respond to an intense public threat and develop the vaccine as quickly as possible, Faden said. But multiple groups had published road maps on how to ethically include pregnant people without slowing down that process.

I cant tell you how many pregnant people might not have died or how many stillbirths might not have occurred if the playbook had been followed, she said, but Im willing to bet it was a significant chunk that would have been prevented if there had been a full-throated, evidence-based recommendation for COVID-19 vaccines in pregnancy almost simultaneous to when it was available for the rest of the adult population.

By the time the CDC specifically recommended the vaccine for pregnant people, in August 2021, the damage had been done.

A dizzying and vague series of advisories led to confusion and delayed vaccinations. When the COVID-19 vaccines were first made available in December 2020, the CDC said health care workers and residents of long-term care facilities should be prioritized, but the shots were not explicitly recommended for pregnant people. Instead, the agency said on its webpage for vaccines and pregnancy that pregnant health care workers may choose to be vaccinated. In explaining that decision, the CDC said that experts had considered how mRNA vaccines, which do not contain the live virus, work. They concluded that the vaccines are unlikely to pose a risk for people who are pregnant.

However, the CDC added, the potential risks of mRNA vaccines to the pregnant person and her fetus are unknown because these vaccines have not been studied in pregnant women.

In January, the World Health Organization recommended against pregnant people getting the vaccine unless they faced increased risk, such as complicating comorbidities or exposure to the virus due to a job in health care, but the agency later reversed course.

A few months later, in March 2021, the CDC continued its lukewarm messaging that pregnant people may choose to be vaccinated. The agency listed some points for pregnant people to consider discussing with their health care providers, starting with how likely they are to be exposed to COVID-19.

After a promising study showed that the vaccine was safe for pregnant people, CDC Director Dr. Rochelle Walensky said at a White House briefing in late April that the CDC was recommending the vaccine for them. But the CDC did not update its website to reflect her comments and said the agencys guidance had not changed: Pregnant people may choose to be vaccinated.

Once again, pregnant people were put in the precarious position of receiving ambiguous and inconsistent recommendations. In May 2021, the CDC reiterated that pregnant people faced an increased risk of getting severely ill from COVID-19, but the language surrounding the vaccine If you are pregnant, you can receive a COVID-19 vaccine was noncommittal.

A CDC spokesperson, responding to questions from ProPublica, said in an email that pregnant people were part of the first recommendations in December 2020 that encouraged people 16 and older to get vaccinated. At that time, data about the safety and efficacy of the vaccine during pregnancy was limited because pregnant people had been excluded from pre-authorization clinical trials, so the CDC included additional supporting language for pregnant people, saying they were eligible and could choose to receive the vaccine. The agency said its recommendations were based on available evidence and evolved throughout the pandemic.

Before making changes to its guidance, the CDC had its team of scientists review available data to ensure that there was an abundance of evidence.

For each update to the statement of risks during pregnancy, multiple types of studies and the strength of evidence for each were reviewed, another CDC spokesperson said. These reviews of the evidence were accompanied with discussions among subject matter experts both internally and externally with clinical partners for an ultimate determination of risk.

Dr. Cynthia Gyamfi-Bannerman, a perinatologist and chair of the department of obstetrics, gynecology and reproductive sciences at the University of California, San Diego School of Medicine, shared the daunting task of making vaccine recommendations for pregnant people as part of COVID-19 task forces for two leading organizations, The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine.

In the beginning, she said, the only pregnancy-specific data they had came from a few dozen participants who were inadvertently included after becoming pregnant during the clinical trials and from some pregnant animal data.

It played out in real time in the COVID pandemic because we see the effects of not including pregnant people in these trials, Gyamfi-Bannerman said. We couldnt make a strong recommendation, so pregnant people were hesitant. I think that directly led to fewer people using the vaccine than we would have wanted.

At the end of June 2021, the CDC added a general update to its website to reflect the dangers of the delta variant tearing across much of the country. Getting vaccinated prevents severe illness, hospitalizations, and death, it wrote. Unvaccinated people should get vaccinated and continue masking until they are fully vaccinated.

But it wasnt until Aug. 11, eight months after the first vaccine was administered, that the CDC issued its formal recommendation that pregnant and breastfeeding people get vaccinated.

The vaccines are safe and effective, Walensky said in a statement at the time, and it has never been more urgent to increase vaccinations as we face the highly transmissible Delta variant and see severe outcomes from COVID-19 among unvaccinated pregnant people.

August would prove to be the deadliest month for COVID-19-related deaths of pregnant people. The CDC issued an emergency call the next month strongly recommending the vaccine to pregnant people, noting that approximately 97% of pregnant people hospitalized with COVID-19 were unvaccinated. The dangers to symptomatic pregnant people included a 70% increased risk of death, and their developing babies could face a host of perils, including stillbirths.

Researchers have yet to determine exactly why some pregnant people with COVID-19, vaccinated and unvaccinated alike, deliver stillborn babies, while others do not. Attempts to answer that question have been hindered, in part, by incomplete data. The CDCs statistics on COVID-19-related fetal and maternal deaths are undercounts. The CDC has data on less than 73,000 birth outcomes following a mothers confirmed COVID-19 diagnosis in 2020 and 2021, of which 579 were pregnancy losses.

That information was sent in by fewer than three dozen health departments, and those estimates dont include states like Mississippi, which in September reported 72 COVID-19-related stillbirths since the start of the pandemic, nearly double what the state would have expected, according to data from the Mississippi State Department of Health. Preliminary state data shows total stillbirths increased there in 2020 then dipped in 2021, but were still higher than pre-pandemic numbers.

A separate CDC database shows more than 220,000 COVID-19 cases and at least 305 deaths among pregnant people.

CDC recognizes that pregnant people faced challenging decisions about how to best protect themselves in the setting of uncertainty related to both the infection and the COVID-19 vaccine, a CDC spokesperson said, adding, COVID-19 vaccination remains one of the best ways to protect yourself and your family from serious illness from COVID-19.

Heartbroken and determined, Jaime Butcher has emerged as an unofficial ambassador for the vaccine, posting in online pregnancy and stillbirth forums about the risks of being pregnant and unvaccinated.

No one, she said, told her of the risks. Doctors, the CDC and health officials, she continued, arent doing enough to inform people. Even now, well into the pandemics third year, the message still isnt getting through.

I kept seeing it happening more and more to women and it wasnt talked about, she said. They just say, Oh, get the vaccine, which is great, but they dont talk about what getting the virus can do to pregnant women.

As a wedding planner, Butcher was surrounded by love. She found it with her husband, then in the daughter growing in her belly, who they named Emily after Butchers grandmother.

Continued here:

God, No, Not Another Case. COVID-Related Stillbirths Didn't Have to Happen. - ProPublica

‘We need to monitor and adjust’ | Some demand COVID-19 safety plans ahead of the new school year starting – WCNC.com

An online petition is gathering signatures to present to local school boards and administrators.

NORTH CAROLINA, USA With multiple variants of the COVID-19 virus, the result has been hundreds of thousands of infections. In some cases, people who have been infected multiple times. With the start of the new school year approaching, health advocates worry without a COVID-19 safety plan within schools, things may worsen.

Long Covid Families is a national nonprofit based in Charlotte that works with patients who experience lasting complications after getting the virus. The organization's concern is that more people may be at risk of getting long COVID.

We now know because of the evolution of the virus that it is very easy for people to get re-infected," Long Covid Families founder Megan Carmilani said. "We dont have a lot of conclusive evidence about what the effect of reinfection is, but the evidence we do have is concerning.

Long Covid Families along with other supporting organizations have created an online open letter, gathering signatures to present to schools boards and administrators about the need for a COVID-19 safety plan in schools.

Part of that plan includes improving classroom ventilation and returning to masks when there is a surge in cases.

"I think we need to monitor and adjust and if we do that wed keep infections down, prevent disability, prevent loss of productivity and loss of learning," Carmilani said.

Some parents add without a plan they're even less likely to feel comfortable sending their at-risk children back into the classroom.

I have twin girls and they are both in the Hospital/Homebound programwith CMS," parent Stacy Staggs said. "A COVID infection for them would be catastrophic."

As part of the COVID-19 safety plan, the need for adequate cleaning supplies, protective gear and janitorial staff is another request.

Starting next week, Long Covid Families is hosting an online Back To School Conference to provide resources on COVID-19 prevention and advocacy in schools. Registration is free.

School Safety & Violence

The Center for Safer Schools sponsored a back to school safety conference in Greensboro this week called The RISE Conference. The conference's title acronym stands for resiliency, information, support, and empowerment.

The goal is to give educators and school leaders the tools to keep students safe.

We want to focus not just on the physical safety, but the mental safety and the school climate because what we know what happens in the community comes into the school," Center for Safer Schools executive director Karen Fairley said.

Some of this week's conversations at the conference included threat assessments, internet crimes against children, bullying and active shooter response. Superintendents, principals, school social workers and school resources officers were all invited to attend and discuss the best school safety decisions together.

"Building better partnerships, being open to have these partnerships because its going to take all of us together to work to keep North Carolina schools safe," Fairley said.

The Center for Safer Schools says the goal is to have more conferences like this in other cities across the state once the new school year begins.

Contact Briana Harper atbharper@wcnc.comand follow her onFacebook,TwitterandInstagram.

More here:

'We need to monitor and adjust' | Some demand COVID-19 safety plans ahead of the new school year starting - WCNC.com

Health officials: San Mateo County’s current COVID-19 surge is lasting longer than most, with transmission still high – The Almanac Online

Medical assistant Monica Magana draws the Moderna COVID-19 vaccine into a syringe at Ravenswood Family Health Center in East Palo Alto on Jan. 30, 2021. Photo by Magali Gauthier.

COVID-19 transmission remains high in San Mateo County, one of the county's top health officials said this week, as the ongoing surge continues to last longer than most previous surges.

According to San Mateo County Health Chief Louise Rogers, the county's census of COVID-related hospitalizations has hovered between 30 and 60 over most of the last three months and was at at 58 as of Monday, Aug. 1.

That figure is lower than the peak of 160 hospitalized patients the county reached during the winter surge of the omicron variant, but is comparable to the peak of last fall's delta variant surge.

Like much of the Bay Area and the state in general, San Mateo County remains in the "high transmission" tier, as outlined by the U.S. Centers for Disease Control and Prevention.

"We continue to strongly recommend wearing a high-quality mask in indoor settings and increasing ventilation -- such as by opening windows and doors where possible -- to help prevent infection," Rogers said in a message to county residents. "We urge residents to test if symptomatic and to be in contact with their physician."

Excerpt from:

Health officials: San Mateo County's current COVID-19 surge is lasting longer than most, with transmission still high - The Almanac Online

Counties with highest COVID-19 infection rates in Rhode Island – What’sUpNewp

Stacker compiled a list of the counties with highest COVID-19 infection rates in Rhode Island using data from the U.S. Department of Health & Human Services and vaccination data from Covid Act Now. Counties are ranked by the highest infection rate per 100,000 residents within the week leading up to August 2, 2022. Cumulative cases per 100,000 served as a tiebreaker.

Keep reading to see whether your county ranks among the highest COVID-19 infection rates in your state.

New cases per 100k in the past week: 140 (115 new cases, +19% change from previous week) Cumulative cases per 100k: 28,300 (23,229 total cases) 23.3% less cases per 100k residents than Rhode Island Cumulative deaths per 100k: 117 (96 total deaths) 65.9% less deaths per 100k residents than Rhode Island Population that is fully vaccinated: 76.2% (62,552 fully vaccinated)

New cases per 100k in the past week: 147 (185 new cases, -4% change from previous week) Cumulative cases per 100k: 29,818 (37,445 total cases) 19.2% less cases per 100k residents than Rhode Island Cumulative deaths per 100k: 193 (242 total deaths) 43.7% less deaths per 100k residents than Rhode Island Population that is fully vaccinated: 80.0% (100,413 fully vaccinated)

New cases per 100k in the past week: 153 (74 new cases, -16% change from previous week) Cumulative cases per 100k: 32,348 (15,682 total cases) 12.4% less cases per 100k residents than Rhode Island Cumulative deaths per 100k: 369 (179 total deaths) 7.6% more deaths per 100k residents than Rhode Island Population that is fully vaccinated: 79.9% (38,755 fully vaccinated)

New cases per 100k in the past week: 166 (1,059 new cases, -4% change from previous week) Cumulative cases per 100k: 38,429 (245,536 total cases) 4.1% more cases per 100k residents than Rhode Island Cumulative deaths per 100k: 405 (2,586 total deaths) 18.1% more deaths per 100k residents than Rhode Island Population that is fully vaccinated: 71.7% (458,022 fully vaccinated)

New cases per 100k in the past week: 194 (319 new cases, +4% change from previous week) Cumulative cases per 100k: 33,936 (55,754 total cases) 8.1% less cases per 100k residents than Rhode Island Cumulative deaths per 100k: 317 (520 total deaths) 7.6% less deaths per 100k residents than Rhode Island Population that is fully vaccinated: 79.5% (130,530 fully vaccinated)

See the original post:

Counties with highest COVID-19 infection rates in Rhode Island - What'sUpNewp

Mills Administration Issues $25 Million in COVID-19 Payments to Support 211 Long-Term Care Organizations | Office of Governor Janet T. Mills -…

Governor Mills proposed and the Legislature approved the payments as part of bipartisan budget to help facilities recover from the pandemic

Governor Janet Mills announced today that her Administration has issued $25 million in one-time COVID-19 payments to 211 long-term care organizations to help them recover from the COVID-19 pandemic. Governor Mills proposed the MaineCare (Medicaid) payments in her supplemental budget that was passed by the Legislature on a bipartisan basis. Additionally, the Maine Department of Health and Human Services (DHHS) is increasing flexibility in the use of these and related funds, such as for fuel and other costs related to global inflation.

Long-term care facilities provide critical services for Maine people, and they are still feeling the impacts of the pandemic challenges that have only been made more difficult by inflation, said Governor Janet Mills. I am proud the Legislature supported my proposal to provide additional funding, and I am pleased we are getting these resources into the hands of our caregivers quickly so they can continue to do their important work it could not come at a better time.

This injection of funding will help long-term care facilities offset unexpectedly high costs such as contract staff, food, and other pandemic-related expenses,said Jeanne Lambrew, Commissioner of the Department of Health and Human Services. The grants are part of unprecedented support for these facilities that not only recognizes their critical role during the COVID-19 pandemic but reflects Governor Mills commitment to making high-quality long-term services and supports affordable and accessible for Maine residents.

Today's announcement is welcome news as Maine's long-term care facilities and their dedicated caregivers continue to feel the impact of COVID-19, said Angela Westhoff, President and CEO of the Maine Health Care Association.Weappreciate Governor Mills' recognition of the persistent strain on providers and are thankful that additional resources are being distributed. We are also pleased with the Administrations response to our request for greater flexibility in the use of these funds with respect to labor costs, as our members persevere toprovide care tothousands of vulnerable Maine citizens each day.

The 211 organizations receiving grants represent 272 service locations throughout the state. The $25 million will be distributed proportionally based on each facilitys 2019 MaineCare revenue and total MaineCare bed days in 2021. For facilities that received little to no MaineCare revenue in 2019, the Department will use revenue from a more recent 12-month period to determine distribution of the supplemental payment amounts by facility.

The Department is also informing long-term care facilities about greater flexibility on the uses of one-time funding to help them recover from the pandemic and combat rising costs associated with inflation. This includes addressing pandemic-related cost increases of hiring and retaining staff and higher expenses, such as for food, fuel, and energy bills. This flexibility applies to the new $25 million announced today as well as to any remaining funds from last years $123 million one-time COVID-19 supplemental payments to nursing facilities, residential care facilities, and adult family care homes.

These payments build on the Mills Administrations historic financial and operational support for nursing facilities, which includes:

This is in addition to at least $50 million in financial relief distributed directly by the Federal government to nursing facilities across Maine.

Pandemic Support: Since the beginning of the pandemic, nursing facilities have submitted and received over 330,000 COVID-19 test results from Maines Health and Environmental Testing Laboratory and these facilities have also placed over 6,400 personal protective equipment (PPE) requests and received over 2.1 million pieces of PPE. Since January 2021, the Department has used over $2 million in Federal funds to support 23,910 hours of emergency nurse and related staffing to nearly one-third of Maine long-term care facilities to support care for residents during the pandemic.

Workforce Training: Recognizing the need to address the workforce challenges exacerbated by the COVID-19 pandemic, Governor Mills included $20 million in theMaine Jobs and Recovery Planto support health care workforce training. This includes scholarships and student loan relief to enable more people to become behavioral health specialists, long term support workers, emergency medical services staff, and other health professionals. The Jobs Plan additionally supports marketing campaigns aimed at promoting health care careers in Maine andHealthcare Training for ME, a program to expand the availability of free and low-cost career training to help health care workers advance their careers, support workforce training needs of health care employers, and attract new workers to fast-growing fields. The Jobs Plan is also supporting the Caring for ME campaign to educate and encourage residents to become direct care providers.

Cabinet on Aging: Governor Mills established the Cabinet on Aging on June 13, 2022 to help Maine prepare for and address demographic changes by advancing policies that will support Maine people in aging safely, affordably, and in ways and settings that best serve their needs. The Cabinet will bring together State government agencies to improve coordination and to accelerate action. It held its first meeting on July 28 and is likely to consider reforms to long-term services and supports in Maine.

The rest is here:

Mills Administration Issues $25 Million in COVID-19 Payments to Support 211 Long-Term Care Organizations | Office of Governor Janet T. Mills -...

A first update on mapping the human genetic architecture of COVID-19 – Nature.com

Yale University, New Haven, CT, USA

Gita A. Pathak&Renato Polimanti

Institute for Molecular Medicine Finland (FIMM), Univerisity of Helsinki, Helsinki, Finland

Juha Karjalainen,Mark Daly,Andrea Ganna&Mark J. Daly

Broad Institute of MIT and Harvard, Cambridge, MA, USA

Christine Stevens,Mark Daly,Andrea Ganna,Masahiro Kanai,Rachel G. Liao,Amy Trankiem,Mary K. Balaconis,Huy Nguyen,Matthew Solomonson,Kumar Veerapen,Samuli Ripatti,Lindo Nkambul,Mark J. Daly,Sam Bryant&Vijay G. Sankaran

Massachusetts General Hospital, Broad Institute of MIT and Harvard, Cambridge, MA, USA

Benjamin M. Neale

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA

Mark Daly,Andrea Ganna,Konrad J. Karczewski,Alicia R. Martin,Elizabeth G. Atkinson,Masahiro Kanai,Kristin Tsuo,Nikolas Baya,Patrick Turley,Rahul Gupta,Raymond K. Walters,Duncan S. Palmer,Gopal Sarma,Matthew Solomonson,Nathan Cheng,Wenhan Lu,Claire Churchhouse,Jacqueline I. Goldstein,Daniel King,Wei Zhou,Cotton Seed,Mark J. Daly,Benjamin M. Neale,Hilary Finucane,F. Kyle Satterstrom&Sam Bryant

Icahn School of Medicine at Mount Sinai, New York, NY, USA

Shea J. Andrews,Laura G. Sloofman,Stuart C. Sealfon,Clive Hoggart&Slayton J. Underwood

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland

Mattia Cordioli,Matti Pirinen,Kati Donner,Katja Kivinen,Aarno Palotie&Mari Kaunisto

Icahn School of Medicine at Mount Sinai, Genetics and Genomic Sciences, York City, NY, USA

Nadia Harerimana

Centre for Bioinformatics and Data Analysis, Medical University of Bialystok, Bialystok, Poland

Karolina Chwialkowska

University of Michigan, Ann Arbor, MI, USA

Brooke Wolford

Ancestry, Lehi, UT, USA

Genevieve Roberts,Danny Park,Catherine A. Ball,Marie Coignet,Shannon McCurdy,Spencer Knight,Raghavendran Partha,Brooke Rhead,Miao Zhang,Nathan Berkowitz,Michael Gaddis,Keith Noto,Luong Ruiz,Milos Pavlovic,Eurie L. Hong,Kristin Rand,Ahna Girshick,Harendra Guturu&Asher Haug Baltzell

Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland

Mari E. K. Niemi&Sara Pigazzini

University of Liege, GIGA-Institute, Lige, Belgium

Souad Rahmouni,Michel Georges&Yasmine Belhaj

CHC Mont-Lgia, Lige, Belgium

Julien Guntz&Sabine Claassen

5BHUL (Lige Biobank), CHU of Lige, Lige, Belgium

Yves Beguin&Stphanie Gofflot

Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland

Mattia Cordioli

Analytic & Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA

Lindokuhle Nkambule,Lindokuhle Nkambul,Lindokuhle Nkambule&Lindo Nkambul

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA

Lindokuhle Nkambule

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA

Lindokuhle Nkambule,Konrad J. Karczewski,Alicia R. Martin,Elizabeth G. Atkinson,Masahiro Kanai,Kristin Tsuo,Nikolas Baya,Patrick Turley,Rahul Gupta,Raymond K. Walters,Duncan S. Palmer,Gopal Sarma,Matthew Solomonson,Nathan Cheng,Wenhan Lu,Claire Churchhouse,Jacqueline I. Goldstein,Daniel King,Wei Zhou,Cotton Seed,Benjamin M. Neale,Hilary Finucane,F. Kyle Satterstrom,Sam Bryant&Caroline Cusick

CHU of Liege, Lige, Belgium

Michel Moutschen,Benoit Misset,Gilles Darcis,Julien Guiot,Samira Azarzar,Olivier Malaise,Pascale Huynen,Christelle Meuris,Marie Thys,Jessica Jacques,Philippe Lonard,Frederic Frippiat,Jean-Baptiste Giot,Anne-Sophie Sauvage,Christian Von Frenckell&Bernard Lambermont

University of Liege, Lige, Belgium

Michel Moutschen,Benoit Misset,Gilles Darcis,Julien Guiot&Samira Azarzar

Department of Human Genetics, McGill University, Montreal, Quebec, Canada

Tomoko Nakanishi

Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

Tomoko Nakanishi,David R. Morrison,J. Brent Richards,Guillaume Butler-Laporte,Vincenzo Forgetta,Biswarup Ghosh,Laetitia Laurent,Danielle Henry,Tala Abdullah,Olumide Adeleye,Noor Mamlouk,Nofar Kimchi,Zaman Afrasiabi,Nardin Rezk,Branka Vulesevic,Meriem Bouab,Charlotte Guzman,Louis Petitjean,Chris Tselios,Xiaoqing Xue,Jonathan Afilalo&Darin Adra

Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Tomoko Nakanishi

Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan

Tomoko Nakanishi

McGill Genome Centre and Department of Human Genetics, McGill University, Montreal, Quebec, Canada

Vincent Mooser,Rui Li,Alexandre Belisle,Pierre Lepage,Jiannis Ragoussis,Daniel Auld&G. Mark Lathrop

Department of Human Genetics, Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada

J. Brent Richards

Department of Twin Research, Kings College London, London, UK

J. Brent Richards

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montral, Qubec, Canada

Guillaume Butler-Laporte

Department of Emergency Medicine, McGill University, Montreal, Quebec, Canada

Marc Afilalo

Emergency Department, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

Marc Afilalo

McGill AIDS Centre, Department of Microbiology and Immunology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

Maureen Oliveira

McGill Centre for Viral Diseases, Lady Davis Institute, Department of Infectious Disease, Jewish General Hospital, Montreal, Quebec, Canada

Bluma Brenner

Research Centre of the Centre Hospitalier de lUniversit de Montral, Montreal, Canada

Nathalie Brassard

Department of Medicine, Research Centre of the Centre Hospitalier de lUniversit de Montral, Montreal, Canada

Madeleine Durand

Department of Medicine, Universit de Montral, Montreal, Canada

Madeleine Durand,Michal Chass&Daniel E. Kaufmann

Department of Medicine and Human Genetics, McGill University, Montreal, Quebec, Canada

Erwin Schurr

Department of Intensive Care, Research Centre of the Centre Hospitalier de lUniversit de Montral, Montreal, Quebec, Canada

Michal Chass

Division of Infectious Diseases, Research Centre of the Centre Hospitalier de lUniversit de Montral, Montreal, Quebec, Canada

Daniel E. Kaufmann

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK

Caroline Hayward,Anne Richmond&J. Kenneth Baillie

Center for Applied Genomics, Childrens Hospital of Philadelphia, Philadelphia, PA, USA

Joseph T. Glessner,Hakon Hakonarson&Xiao Chang

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Joseph T. Glessner&Hakon Hakonarson

Vanderbilt University Medical Center, Nashville, TN, USA

Douglas M. Shaw,Jennifer Below,Hannah Polikowski,Petty E. Lauren,Hung-Hsin Chen,Zhu Wanying,Lea Davis&V. Eric Kerchberger

Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK

Archie Campbell,David J. Porteous&Chloe Fawns-Ritchie

Usher Institute, University of Edinburgh, Nine, Edinburgh Bioquarter, Edinburgh, UK

Archie Campbell

University of Texas Health, Houston, TX, USA

Marcela Morris&Joseph B. McCormick

Department of Psychology, University of Edinburgh, Edinburgh, UK

Chloe Fawns-Ritchie&Chloe Fawns-Ritchie

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Kari North

Center for Applied Genomics, The Childrens Hospital of Philadelphia, Philadelphia, PA, USA

Xiao Chang,Joseph R. Glessner&Hakon Hakonarson

Division of Human Genetics, Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Joseph R. Glessner

Go here to see the original:

A first update on mapping the human genetic architecture of COVID-19 - Nature.com

NEW COVID-19 TESTING METHOD IS AS SENSITIVE AS A PCR TEST, BUT FASTER THAN A LATERAL FLOW TEST – PR Newswire

University of Birmingham (U.K.) signs licensing deal with Innova Medical Group the world's largest COVID-19 at-home self-test provider - to Commercialize New Proven Testing Method in the Global Markets it Serves

PASADENA, Calif., Aug. 4, 2022 /PRNewswire/ -- A unique testing method invented at the University of Birmingham is set for a global rollout after its commercial rights were licensed to the world's largest COVID-19 test provider, Innova Medical Group a California-based global health screening and diagnostics innovator and a world leader in the manufacture and distribution of COVID-19 rapid tests. Known as Reverse Transcription-Free EXPAR (RTF-EXPAR) testing, this new technology offers detection in as little as 10 minutes.

Reverse Transcription-Free EXPAR (RTF-EXPAR) testing offers detection in as little as 10 minutes.

Detailed test evaluations reveal the method delivers a fast, accurate, highly sensitive and simple test for COVID-19 detection, meaning the test could be deployed en masse at entertainment venues, airport arrival terminals, and in remote settings where clinical testing laboratories are not available. The method is just as sensitive as both PCR and LAMP tests - currently used in hospital settings - and is also faster and more sensitive than lateral flow tests, enabling detection at low viral levels. Crucially, it can be used with testing techniques which bypass the need for specialized laboratory equipment, which would reduce delays in waiting for test results, which currently requires samples to be sent to specialist laboratories.

The assay was invented and tested at the University of Birmingham, which found its sensitivity to be equivalent to quantitative PCR testing. This new RTF-EXPAR testing platform is also being adapted for the detection of other viruses, meaning the tests can be quickly adapted to cover both new variants and new viruses. The technology's new license holder, Innova Medical Group, is the world's largest provider of lateral flow tests. The company is aiming to accelerate RTF-EXPAR's global rollout for widespread use by 2023.

The approach behind RTF uses reagents that can be adapted for the detection of other viruses, meaning the tests can be quickly adapted to cover both new variants and other viruses, such as human papillomavirus (HPV) which causes cervical cancer.

"The RTF technology developed at the University of Birmingham hits a testing sweet spot. It's just as sensitive as PCR and LAMP tests, but without the time constraints and laboratory equipment required for these methods," said Robert Kasprzak, Chief Executive Officer at Innova. "We're committed to accelerating RTF's growth and further complementing our current portfolio of healthcare diagnostic products that strengthen the pandemic management solutions we offer to global customers. We've been searching globally for advanced diagnostics technologies to manage the current pandemic and mitigate future healthcare challenges, and we were impressed by the RTF testing method and the team behind it deserves enormous credit for their innovation."

Since the COVID-19 pandemic's outbreak, Innova Medical Group has delivered more than 1.5 billion lateral flow tests to customers worldwide. With this new licensing agreement underscoring its nimble approach and commitment to innovate, the company aims to provide effective, high-quality diagnostic products at reasonable prices to more people around the world."The RTF test rapidly amplifies small quantities of viral genetic material, producing a detectable signal within 10 minutes, which is much faster than PCR or LAMP testing and even quicker than lateral flow tests," said Professor Tim Dafforn from the University of Birmingham. "The reverse transcription and amplification steps slow down existing COVID-19 assays like LAMP and PCR, which are based on nucleic acid detection, thus an ideal test would be both sufficiently sensitive and speedy; the new RTF test achieves that goal in two ways - a new RNA-to-DNA conversion step we designed avoids reverse transcription and the amplification step to generate the read-out signal uses EXPAR, an alternative DNA amplification process."

Professor James Tucker from the University of Birmingham added, "EXPAR amplifies DNA at a single temperature, thus avoiding lengthy heating and cooling steps found in PCR; however, while LAMP also uses a single temperature for amplification, EXPAR is a simpler and a more direct process in which much smaller strands are amplified making it an even faster DNA amplification technique than not only PCR but also LAMP."

For more information on Innova Medical Group, please visit: https://innovamedgroup.com/

About Innova Medical Group, Inc.

Innova Medical Group, wholly owned by Pasaca Capital, Inc., is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions. From delivering more than 2 billion COVID-19 rapid test kits to customers worldwide since the beginning of the pandemic, to providing critical vaccines, including highly sought-after WHO approved COVID-19 vaccines to the world population, Innova is committed to improving the human condition globally. Our strategic and iterative approach enables us to manufacture, distribute, and deploy myriad accessible tests customised to meet and empower the user at their point of need. With a panoramic vision spanning the present to the future, we develop trusted solutions that are both intuitive and secure to use. We quickly and nimbly became the world's largest provider of COVID-19 tests, and we are determined to execute on this model across infectious disease, other chronic conditions, and wellness.

About the University of Birmingham, United Kingdom

TheUniversity of Birminghamis ranked amongst the world's top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 6,500 international students from over 150 countries.

University of Birmingham Enterprisehelps researchers turn their ideas into new services, products and enterprises that meet real-world needs. We also support innovators and entrepreneurs with mentoring, advice, and training and manage the University's Academic Consultancy Service.View our portfolio of technologies available for licensing.

SOURCE Innova Medical Group, Inc.

Continue reading here:

NEW COVID-19 TESTING METHOD IS AS SENSITIVE AS A PCR TEST, BUT FASTER THAN A LATERAL FLOW TEST - PR Newswire

Need to show proof of vaccination? How to store a COVID-19 vaccine card on your smartphone – Yahoo Finance

As new variants of the COVID-19 virus emerge throughout the U.S., a renewed push is being made to get more Americans vaccinated.

As of July 27, about 67% of Americans have been fully vaccinated for COVID, according to Centers for Disease Control and Prevention data.

Last year, with the COVID vaccine becoming available, several policies were introduced by some local governments and companies requiring employees to get the vaccine to return to work. Even Broadway made the same request last year of theatergoers before attending a show.

Of course, you could bring the COVID-19 vaccine card verifying those details with you, which brings not only the annoyance of carrying it everywhere (try fitting that into a wallet), but the fear you wind up losing it.

Thank goodness we have something else in our pockets that can assist: our smartphones. Here are a few ways you can keep your vaccine card handy.

Retirement: Gen Z expects to retire by 63 but underestimates how much money it will need to live on

$300 more for the same insulin: The Medicare rule that makes pump users pay more

Seriously, that's it. If you go this route, consider placing it in a hidden album so it can't be viewed from your library. This also avoids the awkward scenario of having to scroll through the abyss of your camera roll to pull up your vaccine card.

On an iPhone, after you take a picture of your card, go to the Share button on Photos, then select Hide. The image will be placed in a Hidden album you can find by tapping Albums, then scrolling to Utilities.

If you use a Google Pixel or Samsung Galaxy smartphone, you can create locked folders to store your COVID-19 vaccine card.

If you're using an iPhone, scanning your COVID-19 card using the Notes app adds a little more security. To do this, start a new note, then tap on the camera.

Go down to Scan Document and add your card with the built-in scanner. You can then choose to lock it with a passcode. Any time you tap on the note, it will ask you to type a passcode to view.

Story continues

iPhone owners can also add COVID vaccine cards to the Wallet app. You can do this by scanning a QR code offered to the provider who gave your vaccine. Tap the Health app notification to add details to Wallet.

You can do this manually through the Health app by adding the record through your provider (if it's available), then adding the card to Wallet.

Once in Wallet, you can pull up the card as you would gift cards or credit cards. It will show details such as name, vaccine types, and dates of doses.

A handful of health providers support adding a COVID Card to your Android phone.

When you login to the appropriate provider and pull up your vaccine info, you'll tap "save to phone" with Google Pay even if you don't have the Google Pay app, according to a support page from Google. The page also spells out how to access your card if saving as a icon on your Android phone or the Google Pay app.

If you own an Android phone, you can download Samsung's Vaccine Pass to download and access your COVID card.

Multiple state governments have launched apps where users can access their vaccine card information. For those who live in Idaho, Minnesota, New Jersey, and Utah, for example, the Docket app allows residents in those states to view their vaccination status.

For New Yorkers, the Excelsior pass provides residents quick access. California also has its own portal for obtaining a digital vaccine card. Check your state's local health department for details on receiving a digital vaccine card.

Some retailers who offer COVID vaccines also provide digital versions of their records, including Walmart and CVS.

Meanwhile, the service VaxYes allows users to add their vaccine card information and have it transformed into a digital passport which can be added to wallets on Google Pay or Apple Wallet.

The company says all data is encrypted and its service is compliant with HIPAA, which governs how health care professionals must store and protect your data.

This story originally published Aug. 2, 2021.

Follow Brett Molina on Twitter: @brettmolina23.

This article originally appeared on USA TODAY: How to add your COVID vaccination card to your Android, iPhone Wallet

Follow this link:

Need to show proof of vaccination? How to store a COVID-19 vaccine card on your smartphone - Yahoo Finance

Gas demand similar to early days of COVID-19 – Fox Business

Check out what's clicking on FoxBusiness.com.

Gas prices have been declining since mid-June as demand has fallen to levels not seen since the early days of the pandemic, according to AAA.

Prices have continuously declined since June 14, when the average price hit a record high of $5.01 per gallon in the U.S.

A customer pumping gas at a station in Connecticut. (FOX Business/Daniella Genovese / Fox News)

On Thursday, the national average price for a gallon of regular gasoline dropped eight cents to $4.13.

New data from the Energy Information Administration (EIA) shows that gas demand dropped from 9.25 million barrels per day to 8.54 million per day last week.

FORMER OIL EXEC WARNS RECESSION COMES ALONGSIDE ENERGY CRISES: 'GAS WILL EXCEED $5 AGAIN' SOON

That's 1.24 million barrels per day lower than last year and "in line with demand at the end of July 2020," when there were widespread virus-related restrictions and fewer people were hitting the road, according to AAA.

A tanker driver delivers 8,500 gallons of gasoline to an ARCO station in Riverside, California, on May 28, 2022. (AP Photo/Damian Dovarganes / AP Newsroom)

"Despite the steady decrease in pump prices, drivers appear to still be altering their driving habits to contend with higher-than-usual prices," AAA spokesperson Andrew Gross told FOX Business on Thursday.

The latest demand figures bolster a recent AAA survey that revealed 64% of drivers had changed their driving habits or lifestyle since March to offset the high prices at the pump.

BUTTIGIEG HIGHLIGHTS DECLINING GAS PRICES AFTER SUGGESTING THEIR RISE WAS GOOD FOR TRANSITIONING TO EVS

However, there may be some good news for motorists.

Recently, crude prices have fallen as concerns of weaker gasoline demand continue.

According to AAA, if gasoline demand remains low and crude prices don't spike, pump prices are likely to continue falling.

CLICK HERE TO READ MORE ON FOX BUSINESS

Even though the Organization of the Petroleum Exporting Countries (OPEC) and its allies, also known as OPEC+, plan to increase output by only 100,000 barrels a day in September after increasing output by 648,000 barrels per day in July and August, it's unlikely to have a considerable impact on price, according to AAA's report.

"The slight increase is unlikely to have a significant pricing impact, especially if demand continues to decline," AAA said.

The rest is here:

Gas demand similar to early days of COVID-19 - Fox Business

War in Ukraine: latest developments

Here are the latest developments in the war in Ukraine:

Russian authorities in the Crimean Black Sea peninsula -- seized by Moscow from Ukraine in 2014 -- say a small explosive device from a commercial drone, likely launched nearby, hit the navy command in Sevastopol.

The local mayor blames "Ukrainian nationalists" for the attack that forced the cancellation of festivities in the city marking Russia's annual holiday celebrating the navy.

But a spokesman for Ukraine's Odessa region military administration denies Kyiv -- whose nearest positions are some 200 kilometres (125 miles) away -- is responsible, calling the incident "a sheer provocation".

"Ourliberation of Crimea from the occupiers will be carried out in another way and much more effectively," spokesman Sergiy Bratchuk writes on Telegram.

Authorities in Ukraine's southern city of Mykolaiv say widespread Russian bombardments overnight killed at least two civilians including a grain tycoon, as Moscow continues to pummel the sprawling front line.

"Mykolaiv was subjected to mass shelling today. Probably the strongest so far," the city's mayor Oleksandr Senkevych writes on Telegram.

The authorities say leading Ukrainian agricultural magnate Oleksiy Vadatursky, 74, and his wife Raisa were killed when a missile struck their house

Vadatursky, who was ranked Ukraine's 24th richest man with a fortune worth $430 million by Forbes, owned major grain exporter Nibulon and was previously decorated with the prestigious "Hero of Ukraine" award.

A spokesman for the Turkish presidency says there is a "high probability" that a first ship carrying Ukrainian grain could leave Ukraine's port of Odessa on Monday.

That is despite Russian missiles hitting the city in the wake of the July 22 agreement on shipping grain between Russia, Turkey, the UN and Ukraine.

"There is a strong possibility that a first ship could leave tomorrow morning if everything is sorted out by this evening," Ibrahim Kalin says in an interview with Kanal 7 television Sunday.

Story continues

Ukraine's President Volodymyr Zelensky calls for the evacuation of the eastern Donetsk region which has seen fierce clashes between his country's forces and the Russian military.

"There's already a governmental decision about obligatory evacuation from Donetsk region. Please, follow evacuation. At this phase of the war, terror is a main weapon of Russia," he says.

Official Ukrainian estimates put the number of civilians still living in the unoccupied area of Donetsk at between 200,000 and 220,000.

"The decision to leave should be taken at some point. The more people who leave Donetsk region now, the fewer people the Russian army will kill," Zelensky says.

Kyiv and Moscow trade blame over strikes on a jail holding Ukrainian prisoners of war in Kremlin-controlled Olenivka.

Russia's military says 50 Ukrainian servicemen died, including troops who had surrendered after weeks of fighting off Russia's brutal bombardment of the sprawling Azovstal steelworks in the port city of Mariupol.

Ukraine says Russia was behind the attack, with Zelensky accusing the Moscow of the "deliberate mass murder of Ukrainian prisoners of war".

Russia's defence ministry says it has invited the International Committee of the Red Cross (ICRC) and the United Nations to visit the site "in the interests of an objective investigation".

bur-imm/pvh

Read the original post:

War in Ukraine: latest developments

Ukraine military aid doesn’t always get to the front lines: "Like 30% of it reaches its final destination" – CBS News

Watch theCBS Reports documentary "Arming Ukraine" in the video player above, or stream it on the CBS News app Sunday, Aug. 7, at 8 p.m., 11 p.m. or 2 a.m. ET.

In a war being fought largely in World War II era trenches, with Soviet ammunition, the vast influx of modern NATO weapons and military supplies from the West into Ukraine has proven to be among the largest determinants of whether territory is lost, or gained, along Ukraine's embattled border region with Russia.

The bulk of these weapons and military supplies make their way to the border of Poland, where U.S. and NATO allies quickly ferry it across the border and into the hands of Ukrainian officials. That's where U.S. oversight ends.

"All of this stuff goes across the border, and then something happens, kind of like 30% of it reaches its final destination," said Jonas Ohman, founder and CEO of Blue-Yellow, a Lithuania-based organization that has been meeting with and supplying frontline units with military aid in Ukraine since the start of the conflict with Russia-backed separatists in 2014.

"30-40%, that's my estimation," he said in April of this year.

The United States has committed over $23 billion in military aid to Ukraine since the start of the war at the end of February, according to the Kiel Institute for the World Economy, which has been tracking global commitments of aid to Ukraine. The United Kingdom has committed $3.7 billion, Germany $1.4 billion, and Poland $1.8 billion, with multiple other countries following suit.

A combination of Ukraine's constantly shifting front lines with its largely volunteer and paramilitary forces has made delivery of the military aid difficult for those attempting to navigate the dangerous supply lines to their destination. Some have raised concerns about weapons falling into Ukraine's black market, which has thrived on corruption since the collapse of the Soviet Union.

Ohman relies largely on unofficial channels to deliver his supplies, which can include anything from night-vision scopes and radios to Kevlar vests, ballistic helmets and modern drones, which have proven to be essential eyes in the sky for breaking through stalemates on the battlefield. His group's status as an NGO does not permit him to deliver "lethal weapons."

"There are like power lords, oligarchs, political players," Ohman said, describing the corruption and bureaucracy he has to work around. "The system itself, it's like, 'We are the armed forces of Ukraine. If security forces want it, well, the Americans gave it to us.' It's kind of like power games all day long, and so eventually people need the stuff, and they go to us."

Andy Millburn is a retired U.S. Marine colonel who served in Iraq and Somalia and recently founded the Mozart Group, a company dedicated to training frontline Ukrainian soldiers. He traveled to Ukraine after the Russian invasion and set up a base in the capital Kyiv.

"If you provide supplies, or a logistics pipeline, there has got to be some organization to it, right? If the ability to which you're willing to be involved in that stops at the Ukrainian border, the surprise isn't that, oh, all this stuff isn't getting to where it needs to go the surprise is that people actually expected it to," said Millburn.

"If United States' policy is to support Ukraine in the defense of its country against the Russian Federation, you can't go halfway with that. You can't create artificial lines. I understand that means that U.S. troops are not fighting Russians. I understand even U.S. troops are not crossing the border. But why not at least put people in place to supervise the country? They can be civilians to ensure that the right things are happening," he said.

In July, Ambassador Bonnie Denise Jenkins, Under Secretary for Arms Control and International Security at the U.S. State Department, said "the potential for illicit diversion of weapons is among a host of political-military and human rights considerations."

But she added, "We are confident in the Ukrainian Government's commitment to appropriately safeguard and account for the U.S.-origin defense equipment."

Ukraine has created a temporary special commission to track the flow of weapons inside the country. But still, weapons experts say they have seen situations like this before.

"Every country and every situation is very different, but certainly if I look back, Iraq is another country where there have been cyclical deliveries. We saw a lot of weapons come in 2003 with the U.S.-led invasion of Iraq, and then 2014 happened when ISIS took over large parts of the country and took over large stocks of weapons that had been meant for Iraqi forces," said Donatella Rovera, a senior crisis adviser for Amnesty International who has been monitoring human rights violations in Ukraine.

"More recently, we saw the same situation occur in Afghanistan," she said of the U.S. withdrawal and Taliban takeover of the country. "Oversight mechanisms should be in place to avoid that."

"That's one of the reasons we have to win the war," said Ohman. "If we lose the war, if we have this kind of gray zone, semi-failed state scenario or something like that. If you do this you funnel lots of lethal resources into a place and you lose then you will have to face the consequences."

Dymtro Vlasov contributed to this report.

Link:

Ukraine military aid doesn't always get to the front lines: "Like 30% of it reaches its final destination" - CBS News

Western media and the war on truth in Ukraine – Al Jazeera English

Who is winning the war in Ukraine depends on who is doing the talking.

Predictably, Russia says that it is winning as planned, while the United States says Ukraine is pulling a surprise win, thanks to its steadfast resistance and Western support.

On the face of it, authoritarian Russia cannot be trusted with the facts, let alone the truth about the war, while the liberal West inspires greater credibility as it allows for a free and independent inquiry. But in reality, as Chinese military strategist Sun Tzu said, all warfare is based on deception. Neither side could or should be trusted to reduce the fog of war, because both are fully engaged in psychological warfare, which is key to winning the overall war in Ukraine.

In fact, both sides are propagating their own selective facts and myths, while censoring counterclaims, as each needs to maintain an appearance of progress in order to justify big sacrifices in blood or treasure. And both sides need to up the ante in order to harden public resolve behind their goals, which thus far have excluded any serious effort towards a diplomatic solution.

Russia hopes to degrade the morale of the Ukrainian resistance and deflate European support for a war that cannot be won, while the US wants to shore up Ukrainian and European enthusiasm for a winnable war, even if privately, US officials doubt Ukraine could recover all its occupied territories.

While the Russian media has little or no choice but to parrot the official line, Western media has a choice but chooses to trust NATO and Pentagon briefs and reports, regardless of their intentions. Take for example the declaration of an anonymous (why anonymous?) senior Pentagon official that: Russia has committed nearly 85 percent of its military to the war in Ukraine and has removed military coverage from other areas on their border and around the world; Russia still has not figured out how to use combined arms effectively; Russia is taking hundreds of casualties a day. Among Russias military fatalities have been thousands of lieutenants and captains, hundreds of colonels, and many generals.

Now I have no clue if any of this or other such claims are true, and nor I suspect do the officials propagating it or the journalists spreading it. But it is out there, shaping the opinions of the public, the elites and the experts, most of who believe Ukraine is able to pull off some sort of an upset if not an outright victory against its largely more powerful neighbour. But the Western and especially Anglo-American media seems to suffer from short, or should I say selective memory when it takes the official line at face value, as if the official deception during yesterdays wars in Afghanistan, Iraq or Vietnam, has no bearing on covering todays war in Ukraine.

In 2019, theWashington Post newspaper revealed that senior US officials failed to tell the truth about the war in Afghanistan throughout the 18-year campaign, making rosy pronouncements they knew to be false and hiding unmistakable evidence the war had become unwinnable. In other words, they lied. But media outlets, think-tanks and influential pundits continued to rely on these officials; even after it was revealed that they have also lied about another war the Iraq war, which was also fought on false pretence and fabricated evidence.

Official deception was even worse during the Cold War. For example, the Pentagon Papers published about half a century ago revealed that the US government was guilty of an enormous cover-up regarding the terrible losses in the Vietnam war, which led to some 55,000 American and more than a million Vietnamese deaths. Any expectation that US media and the publics trust in the governments take on wars was forever diminished, turned out to be premature, as official lies about the dirty wars in Asia and Central America continued to be widely reported as facts.

Even today, as US Special Operation Command covertly deploys special forces across Africa to fight shadow wars, it blatantly preaches free and transparent press. One does not know whether to laugh or cry.

So it is no surprise that governments, whether autocracies or democracies, lie about wars for tactical or strategic reasons. In fact, there is a fancy name for it stratagem, which means to deliberately send untrue signals to unsettle the enemy while reassuring ones own side.

What is shocking is how the free press in the free world, which to its credit has helped reveal much of the official deception in the past as in the Pentagon Papers and the Afghan Papers, is adamant about echoing and amplifying the official line as if it were complicit in the war.

Watching journalists and pundits in respected American and British journals exhaust the synonyms of fascist, evil and dangerous to describe Russias Putin, with little or no attempt at balance or objectivity, one is inclined to believe that Western media has largely been enlisted in NATOs crusade against Putins Russia until victory. But what does victory entail here: liberating all of Ukraine? Or weakening Russia to the extent it no longer threatens other European countries?

The difference cannot be overstated, because NATOs ultimate objective is to defeat Russia and deter China from following in its footsteps, regardless of the price for Ukraine. That is why both sides seem adamant to continue the fight regardless of the cost. Russia hopes time will force a weakened Ukraine and a wobbly Europe to blink first and eventually back down. And the US is keen on Ukrainians fighting on regardless of whether a victory is achievable, as long as the war exhausts the Russian military and weakens its economy. It is betting that Putins Russia will crack in Ukraine just as the Soviet Union imploded after a decade-long war against the US-supported armed uprising in Afghanistan. But then again, Ukraine is no Afghanistan; not in any relevant way, and Russia does not view it as a disposable geopolitical asset.

So even if Ukraine has in fact managed a surprise upset against the invading Russian forces and forced Moscow into an unexpected war of attrition, it remains far from certain that it could maintain its counter-offensive for another six months, let alone another six years.

The ongoing battle for Kherson may provide a clearer signal about where things are heading. But as long as Western military support remains robust but defensive in nature so as not to risk a nuclear confrontation with Russia, expect the destructive war of attrition to continue in the medium run, or reach a tense stalemate at best, not any form of a decisive victory for either side.

Did someone say diplomacy?!

Read the original:

Western media and the war on truth in Ukraine - Al Jazeera English

Russia-Ukraine war: what we know on day 163 of the invasion – The Guardian

Ukraine has ceded some territory in the Donbas region to Russian forces, with Kyiv acknowledging Russias partial success in recent days. The Ukrainian president, Volodymyr Zelenskiy, has described the pressure his forces are under in the east of the country as hell. They have recaptured two villages near the city of Sloviansk, according to Ukrainian general Oleksiy Hromov, but have been forced to abandon a coal mine regarded as a key defensive position as forces are pushed to the outskirts of Avdiivka.

Russia may launch an offensive in the southern Ukrainian region of Kherson to try to wrest back momentum from Kyiv and has been visibly building up forces, Hromov said on Thursday. Much of the region is already occupied by Russia after it captured areas at the beginning of its invasion, but Ukrainian forces have been developing a counter-offensive to regain territory.

Three more ships carrying grain have been authorised to leave Ukraines ports on Friday as part of an international accord brokered to unblock grain exports and alleviate the global food crisis. The ships are bound for Turkey, Ireland and the UK. Millions of tonnes of grain have been stuck in Ukraine since Russia invaded just over six months ago.

Ukraine will receive another financing package worth about $8bn from the European Union by September, a German government source told Reuters.

Canada is sending up to 225 Canadian armed forces to the UK to recommence the training of Ukrainian military recruits, the Canadian defence minister has announced. Since 2015, Canada has trained 33,000 Ukrainian military and security personnel but in February paused aspects of the training.

Eight people have been killed and four wounded in Russian artillery shelling in the eastern Ukrainian town of Toretsk in Donetsk oblast on Thursday, the regional governor has said. The shelling hit a public transport stop where people had gathered. Three children were among the wounded, said the areas governor, Pavlo Kyrylenko.

Nato members are working closely with defence companies to ensure Ukraine gets more supplies of weapons and equipment to be prepared for a drawn out war with Russia, the Nato secretary general, Jens Stoltenberg, said on Thursday. He told Reuters in an interview: We are providing a lot of support but we need to do even more and be prepared for the long haul.

A US official accused Moscow of preparing to plant fake evidence to make it look like the recent mass killing of Ukrainian prisoners in an attack on a Russian-controlled prison was caused by Ukraine. Kyiv and Moscow have traded blame over the strikes on the prison in Kremlin-controlled Olenivka, in eastern Ukraine, last week.

Amnesty International has said the Ukrainian army is endangering the life of civilians by basing themselves in residential areas. The report has been rejected by Ukrainian government representatives, who say it places blame on Ukraine for Russias invasion. The human rights groups researchers found that Ukrainian forces were using some schools and hospitals as bases, firing near houses and sometimes living in residential flats. Ukraines deputy defence minister, Hanna Maliar, accused Amnesty of distorting the real picture and of failing to understand the situation on the ground.

Original post:

Russia-Ukraine war: what we know on day 163 of the invasion - The Guardian

Russia Steps Up Attacks on Ukrainian Fortifications in the East – The New York Times

Ukrainian soldiers along frontline trenches near Barvinkove in eastern Ukraine on Monday.Credit...David Guttenfelder for The New York Times

DRUZHKIVKA, Ukraine Longstanding strongpoints of Ukraines defense in the east have come under intense attack in recent days, according to the Ukrainian Army and Western military analysts.

That Ukrainian soldiers still hold the trench mazes and fortifications in two suburban towns, Avdiivka and Pisky, on the edge of the city of Donetsk is a testament to the value of their dug-in positions in the east. Ukraines strong defensive positions have slowed the Russian Armys advance to a crawl, with only two large cities, Sievierodonetsk and Lysychansk, and a few dozen miles of territory changing hands despite thousands of soldiers killed on both sides.

It was unclear exactly why assaults on the fortifications have been intensifying, and the assaults are an exception to a general tapering off of Russian attacks in the eastern Donbas region, which had been the focus of the war for months. Some military analysts believe that the relative lull has been partly a result of Russian forces diverting to the south to fend off a Ukrainian counteroffensive there.

The two towns, mostly deserted and destroyed, are hardly big prizes to capture, but if they were to fall, that could ease Russian advances toward the three large cities in the Donetsk region remaining under Ukrainian control, Bakhmut, Kramatorsk and Sloviansk.

The Ukrainian army and paramilitary groups built the fortifications in the two towns during the eight years of low-intensity war after Russias 2014 military intervention in Ukraine to prop up a separatist region, the Donetsk Peoples Republic. They are now among Ukraines easternmost positions.

Weaving through abandoned factories and mines, taking advantage of root cellars in country homes and using swamps as natural barriers, the defensive lines there have withstood countless assaults. After failing to flank Avdiivka, Russia began direct tank assaults this week, according to the Institute for the Study of War, a Washington-based research organization.

The institute noted Russian propaganda videos suggesting that Russian troops had overrun a position at the ventilation shaft of the Butiyka coal mine, which since 2015 had been the closest Ukrainian position to the city of Donetsk, a few miles from what the separatists claim is their capital.

The Ukrainian general staff has said the tank assaults did not push its soldiers from Avdiivka, but noted that they were a partial success, in a possible acknowledgment of the loss of the strategically and politically important position.

For days in a row now, the enemy has not let up on attempts to attack, the Ukrainian military governor of Avdiivka, Vitaliy Barabash, told Radio Liberty on Wednesday. Everywhere is being hit by artillery and aviation bombs.

The Russian military has also fired into the town with rockets that spray flammable material into the air and then ignite it, creating a giant fireball. The Russian thermobaric rocket system, nicknamed the Heatwave, is one of the most destructive weapons in Russias arsenal.

People are living in horrible, inhuman conditions, Mr. Barabash said. He said that about 2,000 civilians remained in Avdiivka out of a pre-invasion population of about 20,000. Every day, the city is shelled about 20 times, he said.

Overall, Russias campaign in Donbas has tapered off in recent weeks after the appearance on the battlefield of American HIMARS, the long-range rocket-launching system used to hit ammunition depots behind Russian lines, and the start of Ukraines counteroffensive around the southern city of Kherson, according to Serhiy Grabskiy, a former Ukrainian army colonel and commentator on the war for the Ukrainian news media. Russia has diverted about 10,000 soldiers from the attack on Sloviansk to defend the south, he said.

Ukrainian forces created in the Donbas quite effective defensive positions over the past several years, Mr. Grabskiy said in a telephone interview. The Russians are frankly stuck in Donbas now without real success, he said. And they have a new headache: the south, which from the perspective of the Ukrainian armed forces is a more important strategic goal.

Read the rest here:

Russia Steps Up Attacks on Ukrainian Fortifications in the East - The New York Times

Before Russia invaded Ukraine, Ilona helped veterans as a social worker. Now shes fighting for her country – ABC News

Ilona has known war for her entire adult life.

When Russia invaded the east in 2014, she and her friends became volunteers to deliver aid. Now aged 25, she Is a private in Ukraine's Territorial Defence Force and awaiting deployment to the front lines.

"I'mpretty sure that it's going tohappen in [the]near future," she told 7.30.

"That's why I spent every minute training."

Ilona was educated as a social worker, intending to care for people and make their lives better.

Now she spends her days training to shoot and to take lives, if necessary.

"I didn't register and mobilise to kill people," she said.

"I mobilised because I love my people. And I'm ready to defend my country.

"So even if I will have to shoot the enemy, I will do it with the love [for]my country and my people."

For the past fiveyears, Ilona has worked with veterans of Ukraine's conflict.

She even visited Australia as part of Ukraine's official team for the Invictus Games in 2018 a memory that makes her break out into a beaming smile.

"It was a very life-changing experience," she said.

"Then [it was] the highest honour to become the team operation manager for the Ukraine [team].

"This is why I think I am so resilient now to stress, because my team taught me a lot that there is no disability, and only capability, and how to be resilient to life."

Ilona is from Kherson,the focus of Ukraine's most significant counteroffensive.

The port city was one of the first to fall under Russian occupation.

"It was hard to see them walking in my streets," she told 7.30.

"The Russians live and stay in theprimary school and the high school that I graduated from."

Ilona is also worried for relatives who remain in her home city.

"I had my mum and my relatives there," she said.

"I just evacuated my mum last week.

"A lot of my friends began serving in 2014. They came back from the war and they went back again, and a lot of them died already killed in action.

"Since February, I have lost about 10 of my very close friends that had combat experience."

Ilona is not alone in the defence forces of Ukraine.

Tens of thousands of women are already serving across all aspects of the military.

"We have a lot of women who are serving in the armed forces and Territorial Defence [Forces]," Alina Frolova, the former deputy defence minister, said.

"I think that around 25 per cent, at least, of all the forces are women so that's [an] extremely big number."

But by October, all Ukrainian women of "fighting age" between 18 and 60 will have to register with the government just as men did before the war started. Those with small children will be excused.

Ms Frolova points out that despite the call for more women, the Ukrainian government is yet to mobilise all the men who registered.

That time may come soon as Ukraine attempts to achieve battlefield successes before the northern winter, along a front line that is more than 1,000 kilometreslong.

Ukraine's government is aware its arms suppliers in Europe and the US are suffering economically because of this war.

"It's critical to gain substantial victories before December, let's say before the end of the year, to demonstrate that this war can be ended up with a military operation that Ukrainians will win," Ms Frolova said.

"And that is why, for us, it's quite critical [and] important to have the necessary weapons to make counteroffensive.

"That's quite simple, because otherwise Russia will constantly blackmail Europe with the gas, with energy supplies, and that will influence on political fluctuations."

Director of the International Crisis Group's European program, Olga Oliker, says every attack by Russia increases Ukraine's motivation to fight.

"A large chunk of Ukraine's success, particularly in the early days, has been the massive mobilisation of the population as a whole, of Ukrainians being willing to fight, to support the fight, to do everything they possibly can do to defend their country," she said.

"You're looking at a country that probably doubled the number of people that had armed in the course of weeks.

"Not all of them [are] effectively trained, not all of them are properly equipped,but people are willing to fight.That's huge."

Soldiers like Ilona areprepared to answer the call to the front line when it comes.

"I must warn you, there's no heroic story likeI came to defend my country or die for my country," she said.

"I just didn't have a choice. There's no excuse [for]why you can't serve.

"We want to live in prosperity, free, in a developed country. Russians wantus dead."

The rest is here:

Before Russia invaded Ukraine, Ilona helped veterans as a social worker. Now shes fighting for her country - ABC News